- Pharmacology
- Allergy, Immunology, and ENT
- Cardiology
- Emergency Medicine
- Endocrinology
- Adolescent Medicine
- Gastroenterology
- Infectious Diseases
- Neurology
- OB/GYN
- Practice Improvement
- Gynecology
- Respiratory
- Dermatology
- Mental, Behavioral and Development Health
- Oncology
- Rheumatology
- Sexual Health
- Pain
Eye on Washington
Majority Leader Frist jumps ship on stem-cell research, and a decision on OTC status for Plan B is imminent—maybe
With Labor Day celebrations completed, Congress reassembled in the Capitol, ready to tackle what remains unresolved of President George W. Bush's 2005 agenda. Now is the time for the Senate Judiciary Committee to grill Supreme Court nominee John G. Roberts on his qualifications for the highest court in the land, and for the Food and Drug Administration (FDA) to make good on a promise to rule on the over-the-counter (OTC) status of Plan B (levonorgestrel), the emergency contraceptive pill. During the congressional recess last month, the president signed into law energy and transportation bills-major legislation stuffed with goodies to placate partisans of all political persuasions.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
